Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia

Name: Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

previously treated myelodysplastic syndrome, recurrent acute myeloid leukemia, recurrent acute myeloid leukemia, myelodysplasia-related, recurrent myelodysplastic syndrome, refractory acute myeloid leukemia, refractory myelodysplastic syndrome

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 383571
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.